Comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 vs 4 Hydroxyphenyllactic Aciduria C1848679
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Impaired Androgen Production and 4 Hydroxyphenyllactic Aciduria for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
A disorder where androgen production is impaired in 46,XY individuals. Results in undervirilization and atypical genital development. Treated with hormone replacement and supportive care.
4 Hydroxyphenyllactic Aciduria C1848679
A metabolic condition affecting how the body processes amino acids. Usually identified in early life. Managed through specialized diet and regular medical follow-up.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
0-0
4 Hydroxyphenyllactic Aciduria C1848679
Variable
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
severe
4 Hydroxyphenyllactic Aciduria C1848679
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
Chronic
4 Hydroxyphenyllactic Aciduria C1848679
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
No
4 Hydroxyphenyllactic Aciduria C1848679
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
reproductive
4 Hydroxyphenyllactic Aciduria C1848679
metabolic
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
endocrine
4 Hydroxyphenyllactic Aciduria C1848679
metabolic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-impaired-androgen-production-C5679870 and 4-hydroxyphenyllactic-aciduria-C1848679 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 Hydroxyphenyllactic Aciduria C1848679 | Discriminating power |
|---|---|---|---|
| Genital development | Undervirilization or atypical genital development may be present from birth. | No genital phenotype is established by the supplied description. | High |
| Metabolic presentation | No amino-acid processing abnormality is described. | Usually identified early and linked to amino-acid metabolism. | High |
| Course | Described as severe and chronic, needing endocrine and supportive care. | Described as moderate and chronic, with diet and follow-up. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 when
Atypical genital findings in a 46,XY infant
The source specifically links impaired androgen production with undervirilization.
High
Need for sex-development evaluation
This concept belongs to the reproductive and endocrine category.
Moderate
Long-term hormone-care planning
Hormone replacement and supportive care are stated management approaches.
Moderate
Choose 4 Hydroxyphenyllactic Aciduria C1848679 when
Abnormal urine organic-acid result
The name denotes 4-hydroxyphenyllactic aciduria, an abnormal metabolite finding.
High
Early-life metabolic concern
The source says identification is usually in early life.
Moderate
Dietary metabolic follow-up
Specialized diet and regular follow-up are the stated management.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870 | 4 Hydroxyphenyllactic Aciduria C1848679 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is part of the concept name. | No karyotype pattern is supplied. | A karyotype supports classification only with clinical and endocrine assessment. |
| Androgen evaluation | Impaired androgen production is the defining mechanism. | No androgen abnormality is described. | Exact cutoffs are not supplied and require clinician interpretation. |
| Urine organic acids | No metabolite pattern is described. | 4-hydroxyphenyllactic aciduria indicates an abnormal result, not automatically one disease. | The finding needs correlation with broader metabolic testing. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Impaired Androgen Production C5679870
- Outcome
- Chronic course is described, but individual outcome is not established.
- Factors
- Severity, androgen impairment, and access to endocrine care.
4 Hydroxyphenyllactic Aciduria C1848679
- Outcome
- Chronic course is described, but prognosis is not established from these data.
- Factors
- Underlying metabolic cause, dietary management, and follow-up.
Time frame: No reliable time frame is supplied.
Etiology and severity differ; clinician assessment is required.
Complications comparison
| Complication | Presentation |
|---|---|
| Undervirilization | May affect genital development. Not described. Specific complications beyond the source are not established. |
| Metabolic imbalance | Not described. Amino-acid processing may be affected. The precise disease association is not established here. |
| Care burden | Hormone replacement and supportive care may be ongoing. Diet and regular follow-up may be ongoing. Neither source gives complication rates. |
Patient education highlights
- HighDifferent conditions
These concepts affect different systems and should not be treated as interchangeable.
- HighResult versus diagnosis
4-hydroxyphenyllactic aciduria may be an abnormal test finding requiring confirmation.
- MediumFollow-up
Specialist interpretation is needed before decisions about hormones, diet, or prognosis.